Infobip becomes Platinum Partner of Rakuten Viber
Global cloud communications platformInfobip has become a Platinum Partner of Rakuten Viber. As a Platinum Partner, Infobip will be able to offer its customers early access to new products and features as well as getting priority access to a knowledge center. Infobip's elevation to Platinum Partner marks another achievement in its ongoing mission to enhance digital communication strategies for businesses worldwide.
CEO of Rakuten Viber, Ofir Eyal, presented Infobip with Viber’s Platinum Partnership Excellence Award at a recent Infobip and Rakuten Viber event. This recognition highlights groundbreaking innovation, significant business growth, and the strong collaboration between Infobip and Rakuten Viber.
Cristina Constandache, Chief Revenue Officer at Rakuten Viber, said: "At Rakuten Viber, we believe that strong partnerships are key to driving mutual growth. Our collaboration with Infobip has fuelled significant innovation and expansion. Infobip achieving the Platinum Partnership status shows our shared commitment to revolutionizing customer engagement with advanced technology and integrated communication solutions."
Silvija Renuša, Business Unit Head of Digital Channels at Infobip, said: "The strong partnership between Infobip and Viber underscores our shared commitment to future-focused, seamless customer experiences. We're proud to have reached the Platinum Partner status in the Rakuten Viber Partner Growth Program, and we look forward to continuing working closely with Viber and shaping the future of customer engagement together."
Over eight years, Rakuten Viber has integrated with Infobip's platform, becoming a key OTT channel. The collaboration has enabled businesses to use Viber for direct, rich media interactions with customers, enhancing user experiences, and helping customers in their digital transformation journey.
One recent example is Metrobank, the second-largest private universal bank in the Philippines. Metrobank partnered with Infobip to integrate Viber rich business messaging into its customer communication strategy, enhancing its operations with a trusted and secure digital platform. Utilizing Infobip's plug-and-play solution, Metrobank seamlessly incorporated Viber business messages into its existing processes with minimal effort. In no time, the bank began delivering personalized, rich content messages, including images and videos, to millions of consenting customers. This strategic move not only created a unique customer experience but also resulted in up to 50% cost savings compared to traditional SMS messaging, as Metrobank effectively communicated its latest offerings through Viber's rich media capabilities.
Ramon Martin Rodriguez, Performance Marketing Head at Metrobank, said: "Infobip provided a solution that enabled us to quickly start benefitting from using Viber for Business for sending marketing messages, using both a portal and an integration with our CRM system. The integration was extremely easy to set up with no disruption to our businesses processes, and no requirement to involve technical resources from other departments. We have been very satisfied with the entire process."
Learn more about the Metrobank success story: https://www.infobip.com/customer/metrobank
About Infobip
Infobip is a global cloud communications platform that enables businesses to build connected experiences across all stages of the customer journey.
About Rakuten Viber
Rakuten Viber is one of the most trusted and downloaded apps in the world. We create meaningful connections, bringing people together safely, so they can enjoy precious moments with their families and friends, manage their business relations, or pursue their passions, in one place - we do it all! As a super app, we give our users services that cover every aspect of their day-to-day needs and make their lives easier. Rakuten Viber is part of Rakuten Group, Inc., a global technology leader in e-commerce, fintech, digital content, and communications services.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250409859460/en/
Contacts
For more information, contact:
Marcelo Nahime
marcelo.nahime@infobip.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press Release
Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships Powering the Summit CoMotion GLOBAL 2025 is hosted by the Saudi Conventions & Exhibitions General Authority (SCEGA), supported by key Saudi
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press Release
Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. These findings further reinforce rusfertide’s efficacy and safety and demonstrate durability of response, with 61.9% of patients continuously treated with rusfertide maintaining absence of phlebotomy eligibility from baseline to Week 52. “The 52-week data demonstrated the sustained efficacy of rusfertide, reducing the need for patients to receive phlebotomy while maintaining hematocrit control,” said Dr. Andrew T. Kuykendall, M.D., VERIFY Lead Investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “The 32-week VERIFY primary results were already promising, and this deeper understanding of the durability of r
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press Release
Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood
Vertex Presents New Data on CASGEVY ® , Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and TDT ages 12 years and older, will be presented at the American Society of Hematology (ASH) Annual Meeting. CASGEVY is currently approved for eligible people ages 12 years and older with SCD or TDT in the United States, Great Britain, the European Union, the Kingdom of Saudi Arabia, the Kingdom of Bahrain, Kuwait, Qatar, Canada, Switzerland and the United Arab Emirates. “These results — the first clinical data ever presented on any genetic therapy for children ages 5-11 years with SCD — again demonstrate the tr
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press Release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom